
|Videos|October 13, 2020
Dr. Ben Chew discusses kidney stones and metabolic syndrome
Author(s)Urology Times staff
"Treat the patient as a whole, not just as a stone former," Chew advises.
Advertisement
In this interview, Ben H. Chew, MD, MSc, associate professor of urologic sciences at the University of British Columbia, Vancouver, discusses findings from the recent Journal of Endourology paper, “Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life,” for which he served as a study author.
More videos:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












